Drug
Docetaxel Plinabulin
Docetaxel Plinabulin: highest development phase Phase 3, developed by BeyondSpring. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BeyondSpring
Trials
| Drug | Phase | Indication |
|---|---|---|
| Docetaxel + Plinabulin (DP) NCT02504489 | Phase 3 | Non-Small Cell Lung Cancer |
Latest
No recent events.
Follow Docetaxel Plinabulin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.